Blog

The New York Times – Business:

The German company CureVac hopes its RNA vaccine will rival those made by Moderna and Pfizer-BioNTech. It could be ready next month.

The New York Times – Business:

The panel of about 20 people, including academics and political leaders, will decide whether the company’s ban of former President Donald J. Trump will remain in effect.

The New York Times – Business:

The New York Times – Business:

The cryptocurrency that started as a joke is up by roughly 14,000 percent this year.

The New York Times – Business:

The New York Times – Business:

As Americans with disposable income start shopping again, an odd assortment of products like coffee makers, sofas and natural deodorant have become sudden hot properties.

The New York Times – Business:

Goldman Sachs is the latest to call an end to remote work.

The New York Times – Business:

The publisher added 301,000 digital subscribers for the first quarter, the slowest gain in over a year. Profits jumped, beating Wall Street expectations.

The New York Times – Business:

One key economic goal is to create the virtuous cycles of innovation and jobs that already occur in many coastal cities.

The New York Times – Business:

The world beckons, especially for those who have been vaccinated, but would-be travelers face a difficult moment when travel possibilities are at odds with the facts of a still reeling world.